SCHEMBL3823317

SCHEMBL3823317

CC(=O)N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C1CCCN(OC(=O)OC(C)C)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CETP P11597 16/20 0.51
TACR1 P25103 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3823604 0.92 CETP (0.62) CETP
SCHEMBL3827831 0.92 CETP (0.55) CETP
SCHEMBL3843347 0.89 CETP (0.55) CETP
SCHEMBL4770930 0.89 CETP (0.49) CETP
SCHEMBL4772571 0.89 CETP (0.49) CETP
SCHEMBL4768343 0.87 CETP (0.49) CETP
SCHEMBL1383212 0.87 CETP (0.56) CETPTACR1
SCHEMBL4777167 0.87 CETP (0.50) CETPTACR1
SCHEMBL4770787 0.87 CETP (0.50) CETPTACR1
SCHEMBL3826990 0.86 CETP (0.49) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670768-B1 COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA LILLY CO ELI (US) 2009-09-09 EP claimed